{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:54:01Z","timestamp":1761854041288,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":93,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.nefroe.2023.06.001","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T20:38:30Z","timestamp":1687639110000},"page":"257-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bilateral hip osteonecrosis and cholelithiasis after eculizumab discontinuation in atypical haemolytic uraemic syndrome"],"prefix":"10.1016","volume":"43","author":[{"given":"Mercedes","family":"Ubetagoyena Arrieta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Montes Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyre","family":"Perez Sukia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2023.06.001_bib0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/j.ajkd.2011.11.027","article-title":"Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants","volume":"59","author":"Ariceta","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nefroe.2023.06.001_bib0010","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00467-018-3933-3","article-title":"Extra-Renal manifestations of atypical hemolytic uremic syndrome in children","volume":"33","author":"Fidan","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2023.06.001_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0049-0172(05)80026-5","article-title":"Osteonecrosis: current perspectives on pathogenesis and treatment","volume":"23","author":"Chang","year":"1993","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.nefroe.2023.06.001_bib0020","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00467-018-4105-1","article-title":"Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli","volume":"34","author":"Khalid","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nefroe.2023.06.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.nefro.2019.01.001","article-title":"Eculizumab en el s\u00edndrome hemol\u00edtico ur\u00e9mico at\u00edpico. \u00bfHasta cu\u00e1ndo mantenerlo?","author":"Naranjo Munoz","year":"2019","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefroe.2023.06.001_bib0030","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00467-019-4192-7","article-title":"Optimal duration of treatment with eculizumab in atypical hemolytic uremic syndrome (aHUS)\u2014a question to be addressed in a scientific way","volume":"34","author":"Ariceta","year":"2019","journal-title":"Pediatr Nephrol"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251423000937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251423000937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:50:39Z","timestamp":1761853839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251423000937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2013251423000937"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2023.06.001","relation":{},"ISSN":["2013-2514"],"issn-type":[{"type":"print","value":"2013-2514"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilateral hip osteonecrosis and cholelithiasis after eculizumab discontinuation in atypical haemolytic uraemic syndrome","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2023.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2021.03.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}